Jeff Shimizu

Progenity (United States)

Papers

1

Total Citations

15

H-Index

1

About

Jeff Shimizu is a biomedical engineer whose research focuses on the frontier of ingestible capsule robots (ICRs) and advanced drug delivery systems. His work is central to overcoming the formidable biological barriers that prevent biologic macromolecule drugs—such as proteins and antibodies—from being administered orally. Shimizu’s major contribution lies in the systematic optimization of tissue attachment mechanisms for drug-delivering capsules, a critical step toward making needle-free, oral biologic therapies a reality. His most-cited paper, “A Factorial Approach for Optimizing the Design Parameters of a Tissue Attachment Mechanism for Drug Delivery” (2021, 15 citations), exemplifies his methodical approach: using factorial design to pinpoint the ideal combination of mechanical and material parameters for secure capsule anchoring in the GI tract. This work directly addresses the instability and immunological hurdles that have long stymied oral biologics. By engineering the interface between device and tissue, Shimizu is helping to transform the ICR from a diagnostic tool into a versatile therapeutic platform. His research stands at the intersection of mechanical design, materials science, and pharmaceutical engineering, offering a tangible path toward less invasive, more patient-friendly treatments for chronic diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
A Factorial Approach for Optimizing the Design Parameters of a Tissue Attachment Mechanism for Drug Delivery
15 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Progenity (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago